A plan setting out the life sciences industry priorities in response to Covid-19 and to support continuing growth across the key economic sector has been published.
The Life Sciences Scotland Industry Leadership Group has identified three areas of focus to ensure patients have access to new and existing treatments and services and that the sector continues its remarkable growth.
The Scottish Life Sciences Covid-19 Strategic Response Plan details the three priorities which the leadership group believes will help Scotland’s people, industry and economy:
- Pharmaceutical supply chain and innovation
- Health Technology
- Animal Health, Agritech and Aquaculture
Scotland's life sciences sector currently employs more than 41,000 people across 770 organisations with an annual turnover of £6.5 billion. The industry, which is at the forefront of the response to the COVID-19 pandemic, continues to record growth and significant investment. UK-wide, the life sciences industry employs 256,100 people in 6,300 businesses and generates a turnover of £80.7 billion per annum.
You can read more about the plan on the Life Sciences Scotland website or download a PDF copy of the document below.
The Scottish Life Sciences Covid-19 Strategic Response Plan
Opportunity North East Ltd
11 Queens Gardens
Aberdeen
AB15 4YD